Literature DB >> 3761168

Biliary excretion and enterohepatic cycling of glycyrrhizin in rats.

T Ichikawa, S Ishida, Y Sakiya, Y Sawada, M Hanano.   

Abstract

The enterohepatic cycling of glycyrrhizin was examined using rats with and without biliary fistulization. The plasma decay in the control rats without fistulization following an iv dose of 100 mg/kg of glycyrrhizin, was generally biphasic. However, secondary peaks were observed in all rats in the elimination phase, i.e., 0.5 to 12 h following dosing. The plasma concentrations in the rats with biliary fistulization administered the same dose showed a biexponential decline. The AUC and CLtot were significantly higher and lower in the control rats, respectively. The biliary excretion was 80.6 +/- 9.9% of the administered dose, and intestinal absorption was confirmed by using the bile collected after iv dosing. From these results, we concluded that glycyrrhizin was predominantly secreted from the liver into the bile, and that the secondary peaks in the elimination phase, the higher AUC, and the lower CLtot in the control rats were due to the effects of enterohepatic recycling of glycyrrhizin. Furthermore, the transport of the drug from the liver to the bile appears to be a saturable process.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3761168     DOI: 10.1002/jps.2600750711

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Evidence for dissolution rate-limited absorption of COL-3, a matrix metalloproteinase inhibitor, leading to the irregular absorption profile in rats after oral administration.

Authors:  Jing Li; Hung Huynh; Eli Chan
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

Review 2.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

Review 3.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

4.  Pharmacokinetics of magnesium glycyrrhizinate following intravenous administration of magnesium glycyrrhizinate in rats.

Authors:  Qin Hu; Jianhua Ding; Suyi Liu; Pin Li; Gang Hu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Oct-Dec       Impact factor: 2.441

5.  Pharmacokinetics of methylergometrine in the rat: evidence for enterohepatic recirculation by a linked-rat model.

Authors:  U Bredberg; L Paalzow
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

6.  Intestinal absorption and biliary elimination of glycyrrhizic acid diethyl ester in rats.

Authors:  Kenjiro Koga; Mayuri Kawamura; Hiroshi Iwase; Nobuji Yoshikawa
Journal:  Drug Des Devel Ther       Date:  2013-10-21       Impact factor: 4.162

7.  Distribution Analysis via Mass Spectrometry Imaging of Ephedrine in the Lungs of Rats Orally Administered the Japanese Kampo Medicine Maoto.

Authors:  Takashi Matsumoto; Hirotaka Kushida; Shoko Matsushita; Yoshiyuki Oyama; Takafumi Suda; Junko Watanabe; Yoshio Kase; Mitsutoshi Setou
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.